Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-29 Purchase |
2024-01-31 4:26 pm |
Tourmaline Bio Inc. | TRML | MCDADE MARK Director |
100,000 | $32.5 | $3,250,000 | 742,209 (Indirect Direct) |
View |
| 2023-01-27 Purchase |
2023-04-11 7:55 pm |
Jasper Therapeutics Inc. | JSPR | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK RIESCHEL GARY E 10% Owner |
2,666,666 | $1.5 | $3,999,999 | 8,519,648 (Direct) |
View |
| 2022-04-01 Purchase |
2022-04-05 4:10 pm |
Icosavax Inc. | ICVX | MCDADE MARK Director |
42,225 | $7.1 | $299,798 | 3,560,471 (Indirect Direct) |
View |
| 2021-08-02 Purchase |
2021-08-02 9:27 pm |
Icosavax Inc. | ICVX | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK Former 10% Owner |
221,351 | $15 | $3,320,265 | 3,523,561 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director |
7,840 | $34.5 | $270,480 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-05 Option Award |
2024-06-07 4:03 pm |
N/A 2034-06-04 |
Tourmaline Bio Inc. | TRML | MCDADE MARK Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-02-19 Equity Swap |
2024-02-20 7:38 pm |
N/A N/A |
Icosavax Inc. | ICVX | MCDADE MARK See Remarks |
3,566,014 | $0 | 0 (Direct) |
View |
| 2023-10-23 Option Award |
2023-10-23 8:26 pm |
N/A 2033-10-22 |
Tourmaline Bio Inc. | TRML | MCDADE MARK Director |
368,949 | $0 | 662,209 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-14 6:59 pm |
N/A 2033-06-13 |
Talaris Therapeutics Inc. | TALS | MCDADE MARK Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 8:46 pm |
N/A 2033-06-05 |
Icosavax Inc. | ICVX | MCDADE MARK Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 4:12 pm |
N/A 2032-06-09 |
Icosavax Inc. | ICVX | MCDADE MARK Director |
27,821 | $0 | 3,588,292 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 6:20 pm |
N/A 2032-06-08 |
Talaris Therapeutics Inc. | TALS | MCDADE MARK Director |
14,501 | $0 | 14,501 (Direct) |
View |
Ownership |
2021-10-01 4:08 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK 10% Owner |
0 | $0 | 5,852,982 (Direct) |
View |
| 2021-08-02 Conversion |
2021-08-02 9:27 pm |
N/A N/A |
Icosavax Inc. | ICVX | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK Former 10% Owner |
17,066,543 | $0 | 3,523,561 (Direct) |
View |
Ownership |
2021-07-28 9:17 pm |
N/A N/A |
Icosavax Inc. | ICVX | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK Director 10% Owner |
0 | $0 | 3,310,228 (Direct) |
View |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director |
26,852 | $34.5 | 0 (Direct) |
View |
| 2020-05-27 Option Award |
2020-05-29 7:13 pm |
N/A 2030-05-26 |
Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director |
23,238 | $0 | 50,090 (Direct) |
View |